Form 4 holding
Director
Dianthus Therapeutics, Inc. /DE/
- Security class
- Common Stock
- Shares / value
- 2,717,554
- Estimated value
- $32,610,648
- Report date
- 22 Jan 2024
- Price
- $12.00
- Ownership
- Indirect
Lei Meng - Director at Dianthus Therapeutics, Inc. /DE/
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- DNTH on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Lei Meng since 23 Aug 2025
Reported holdings for Lei Meng in Dianthus Therapeutics, Inc. /DE/
Form 4 holding
Director
Dianthus Therapeutics, Inc. /DE/
- Security class
- Pre-Funded Warrants (Right to Buy)
- Shares / value
- 1,833,333
- Estimated value
- $21,998,163
- Report date
- 22 Jan 2024
- Price
- $12.00
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Dianthus Therapeutics, Inc. /DE/
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 6,500
- Estimated value
- Report date
- 11 Sep 2023
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Lei Meng in Dianthus Therapeutics, Inc. /DE/
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.